NCT07156227 2026-06-03Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell CarcinomaNational Cancer Institute (NCI)Phase 1 Recruiting39 enrolled